CA Retrans Capsule
CA Retrans Capsule belongs to a group of medicines called retinoids, which are similar to vitamin A. It is used to treat a type of blood problem called acute promyelocytic leukaemia. It works by slowing the growth of certain types of diseased blood cells.
CA Retrans Capsule
Basic Information
Important information about this medicine
About This Medicine
General information about this product
CA Retrans Capsule belongs to a group of medicines called retinoids, which are similar to vitamin A. It is used to treat a type of blood problem called acute promyelocytic leukaemia. It works by slowing the growth of certain types of diseased blood cells.
CA Retrans Capsule belongs to a group of medicines called retinoids, which are similar to vitamin A. It is used to treat a type of blood problem called acute promyelocytic leukaemia. It works by slowing the growth of certain types of diseased blood cells.
CA Retrans Capsule works by slowing the growth of certain types of diseased blood cells. It should be taken with food, preferably at the same time, each day, to avoid a missed dose. It may take several weeks for your symptoms to improve but keep using it regularly to get the most benefit. If you notice no improvement after a few weeks, see your doctor again. Using more medicine or applying it more often than prescribed will not make it work any faster and may increase side effects.
The most common side effects include headache, fever, dry skin and rash. They are not usually serious and often disappear after getting used to the cream but if they bother you or do not go away, tell your doctor. You may need to apply smaller amounts or use it less often. Serious side effects are rare.
CA Retrans Capsule may make you more sensitive to sunlight so you should limit exposure to the sun if possible. Drink plenty of water and use moisturizer as it may lead to dryness of the mouth, lips, and eyes. It may make your skin more fragile. It is advised, not to have any waxing (hair removal), or laser treatments during treatment. This medicine may lead to birth defects, do consult your doctor if you are pregnant or planning to get pregnant.
03Uses
Treatment of Acne
Acute promyelocytic leukaemia
04How To Use
Take this medicine in the dose and duration as advised by your doctor. CA Retrans Capsule is to be taken with food.
05How It Works
CA Retrans Capsule is a form of vitamin A. To treat blood cancer, it works by slowing the growth of certain types of diseased blood cells, and promotes the growth of normal, mature cells in the bone marrow and blood. This helps to treat blood cancer (acute promyelocytic leukemia).
06What If You Miss A Dose?
Q: What if you forget to take CA Retrans Capsule?
A: If you miss a dose of CA Retrans Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Treatment of Acne
CA Retrans Capsule is a form of vitamin A. It helps treat acne by clearing skin pores and preventing spots or pimples from appearing. It usually takes several weeks to have a noticeable effect so keep using it even if it appears not to be working. Sometimes acne may get worse before it gets better, however, with proper use, your skin will get clearer. The earlier you start using it, the less likely you are to get scars. This medicine will help improve your mood and uplift your confidence as your skin becomes acne-free. It should not be used if you have eczema or sunburned skin.
08Side Effects
Headache
Fever
Bone pain
Rash
Visual impairment
Hair loss
Increased sweating
Mucosal inflammation
Erythema (skin redness)
Skin irritation
Dry skin
Dry lips
Pale red skin
Increased sensitivity to light
09Safety Information
Alcohol:CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with CA Retrans Capsule. Please consult your doctor.
Pregnancy:CONSULT YOUR DOCTOR
CA Retrans Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding:SAFE IF PRESCRIBED
CA Retrans Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving:UNSAFE
CA Retrans Capsule may cause side effects which could affect your ability to drive.Your ability to drive might be impaired while you are taking CA Retrans Capsule, especially if you are feeling dizzy or have a severe headache.
Kidney:CONSULT YOUR DOCTOR
There is limited information available on the use of CA Retrans Capsule in patients with kidney disease. Please consult your doctor.However, a cautious use of this medicine is advised in these patients.
Liver:CONSULT YOUR DOCTOR
There is limited information available on the use of CA Retrans Capsule in patients with liver disease. Please consult your doctor.However, a cautious use of this medicine is advised in these patients.
10Drug Tips
CA Retrans Capsule helps in the treatment of blood cancer.
Take it with or just after food.
This medicine is usually taken until there is no sign of cancer (you are in remission) or for a maximum of 90 days.
Chemotherapy may be started during treatment with this medicine, or immediately after you stop taking it.
Do not take CA Retrans Capsule if you are pregnant, planning pregnancy or breastfeeding as it can cause birth defects in babies.
Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for 1 month after you stop taking it.
Do not take any kinds of vitamin supplements without talking to your doctor first.
Your doctor may get regular blood tests done to monitor your blood lipid levels, liver function, blood cell count in your blood.
Do not use CA Retrans Capsule if you are pregnant.
Inform your doctor if excessive skin dryness or skin sensitivity takes place.
References
Sources and references
Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1810.
Sardana K, Madan A. How to Treat Acne. Sardana K, editor. In: Clinical Approach to Acne Vulgaris. 1st ed. New Delhi: CBS Publishers & Distributors Pvt. Ltd.; 2015. pp. 35-36.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1395.
Tretinoin. Nutley, New Jersey: Roche Laboratories Inc.; 2004. [Accessed 23 Jul. 2019] (online) Available from: View
Tretinoin. Mesekenhagen Germany: Cheplapharm Arzneimittel GmbH; 1996 [revised 25 Apr. 2017]. [Accessed 03 Apr. 2019] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). [Accessed 03 Apr. 2019] (online) Available from: View
